Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001053369-14-000006)

Filing Details

Accession Number:
0001053369-14-000006
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2014-01-06 17:49:02
Reporting Period:
2013-11-15
Filing Date:
2014-01-06
Accepted Time:
2014-01-06 17:49:02
Original Submission Date:
2013-11-14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1053369 Elite Pharmaceuticals Inc ELTP Pharmaceutical Preparations (2834) 223542636
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1442002 Epic Pharma Llc 227-15 North Conduit Ave
Laurelton NY 11413-3134		 No No Yes No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-11-15 253,050 $0.12 72,950,493 No 4 S Indirect By Epic Investments, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Epic Investments, LLC
Footnotes
  1. The reporting person, Epic Pharma, LLC ("EP") owns 100% of the outstanding equity interests, is an equity owner of Epic Investments, LLC ("EI"). The interest of EP in the securities of the issuer owned by EI is limited, and EP disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.
  2. This amended form 4 is to correct the original Form 4/A filed on this same date to reflect the shares were disposed of and not acquired. The original Form 4/A was filed with an (A) in column 4 when the correct code is (D).